Literature DB >> 32714443

Antisynthetase syndrome in pregnancy: A case and review of the literature.

Lauren J Green1, Lorraine O'Neill2, Charlotte J Frise1.   

Abstract

Antisynthetase syndrome is a rare autoimmune, multisystem, inflammatory condition, characterised by autoantibodies against aminoacyl tRNA synthetases. The predominant features are myositis and interstitial lung disease but other symptoms such as Raynaud's phenomenon may also be present. Described here is a 36-year-old woman with antisynthetase syndrome who planned and underwent a successful pregnancy, during which a multidisciplinary team approach secured a good outcome for both mother and baby.
© The Author(s) 2018.

Entities:  

Keywords:  Antisynthetase syndrome; anti-Ro antibodies; inflammatory myopathy; pregnancy

Year:  2018        PMID: 32714443      PMCID: PMC7359659          DOI: 10.1177/1753495X18808646

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  17 in total

1.  BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.

Authors:  Julia Flint; Sonia Panchal; Alice Hurrell; Maud van de Venne; Mary Gayed; Karen Schreiber; Subha Arthanari; Joel Cunningham; Lucy Flanders; Louise Moore; Amy Crossley; Neetha Purushotham; Amisha Desai; Madeleine Piper; Mohamed Nisar; Munther Khamashta; David Williams; Caroline Gordon; Ian Giles
Journal:  Rheumatology (Oxford)       Date:  2016-01-10       Impact factor: 7.580

2.  In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease.

Authors:  R La Corte; A Lo Mo Naco; A Locaputo; F Dolzani; F Trotta
Journal:  Autoimmunity       Date:  2006-05       Impact factor: 2.815

Review 3.  The clinical spectrum of neonatal lupus.

Authors:  Lela A Lee
Journal:  Arch Dermatol Res       Date:  2008-09-17       Impact factor: 3.017

Review 4.  Neonatal lupus erythematosus: clinical findings and pathogenesis.

Authors:  Lela A Lee
Journal:  J Investig Dermatol Symp Proc       Date:  2004-01

Review 5.  Follow-up of children exposed antenatally to immunosuppressive drugs.

Authors:  M Motta; A Tincani; P L Meroni; R Cimaz
Journal:  Rheumatology (Oxford)       Date:  2008-06       Impact factor: 7.580

6.  Outcomes of children exposed in utero to chemotherapy for breast cancer.

Authors:  Rashmi K Murthy; Richard L Theriault; Chad M Barnett; Silvia Hodge; Mildred M Ramirez; Andrea Milbourne; Sue A Rimes; Gabriel N Hortobagyi; Vicente Valero; Jennifer K Litton
Journal:  Breast Cancer Res       Date:  2014-12-30       Impact factor: 6.466

Review 7.  Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management.

Authors:  Alban-Elouen Baruteau; Robert H Pass; Jean-Benoit Thambo; Albin Behaghel; Solène Le Pennec; Elodie Perdreau; Nicolas Combes; Leonardo Liberman; Christopher J McLeod
Journal:  Eur J Pediatr       Date:  2016-06-28       Impact factor: 3.183

Review 8.  Management of systemic lupus erythematosus during pregnancy: challenges and solutions.

Authors:  Caroline L Knight; Catherine Nelson-Piercy
Journal:  Open Access Rheumatol       Date:  2017-03-10

9.  Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

Authors:  Yasuhito Hamaguchi; Manabu Fujimoto; Takashi Matsushita; Kenzo Kaji; Kazuhiro Komura; Minoru Hasegawa; Masanari Kodera; Eiji Muroi; Keita Fujikawa; Mariko Seishima; Hidehiro Yamada; Ryo Yamada; Shinichi Sato; Kazuhiko Takehara; Masataka Kuwana
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.

Authors:  Isabelle Marie; Pierre-Yves Hatron; Patrick Cherin; Eric Hachulla; Elisabeth Diot; Olivier Vittecoq; Jean-François Menard; Fabienne Jouen; Stéphane Dominique
Journal:  Arthritis Res Ther       Date:  2013-10-08       Impact factor: 5.156

View more
  2 in total

1.  A 25-Year-Old Saudi Woman with a 2-Year History of Antisynthetase Syndrome with Interstitial Lung Disease Who Commenced Azathioprine Treatment in the Third Trimester of Pregnancy and Had a Successful Birth at Term.

Authors:  Lama A Alshwairikh; Zeneb Babay
Journal:  Am J Case Rep       Date:  2022-07-07

2.  Antisynthetase Syndrome with Severe Interstitial Lung Disease in Pregnancy.

Authors:  Catalina I Dumitrascu; David A Olsen; Katherine W Arendt; Carl H Rose; Emily E Sharpe
Journal:  Case Rep Anesthesiol       Date:  2021-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.